What is Urolithin A?
Urolithin A is one of the most exciting natural compounds in the longevity space — and one of the few with genuine Phase II human RCT data showing improvements in physical performance. It's produced when gut bacteria metabolize ellagitannins — polyphenolic compounds found in pomegranates, walnuts, and certain berries. The problem: only about 30–40% of people have the right gut microbiome composition to produce meaningful amounts of Urolithin A from dietary sources. Everyone else produces little or none, regardless of how much pomegranate they eat. This is why supplemental Urolithin A exists.
Urolithin A's primary mechanism is mitophagy induction — the cellular process that selectively removes damaged, dysfunctional mitochondria. Mitophagy is to mitochondria what autophagy is to the cell broadly: a quality control mechanism that clears out damaged components before they impair function. As cells age, mitophagy declines — damaged mitochondria accumulate, cellular energy production becomes less efficient, and ROS production increases. Urolithin A activates mitophagy via PINK1/Parkin signaling, accelerating the removal of dysfunctional mitochondria and improving the quality of the remaining mitochondrial pool.
The human evidence from Timeline's clinical program is meaningful. A Phase II RCT in older adults (65–90) showed Urolithin A (Mitopure, 1000 mg/day, 4 months) significantly improved 6-minute walk distance, muscle strength (handgrip, leg press), and mitochondrial gene expression vs. placebo. Muscle biopsies showed increased mitochondrial biogenesis and reduced mitochondrial stress markers. For a supplement compound (not a drug), this is unusually rigorous evidence.
Urolithin A fits neatly into the mitochondrial longevity stack alongside MOTS-c (AMPK activation and metabolic signaling), SS-31 (inner mitochondrial membrane protection), and NAD+ (fuel for mitochondrial enzymes). Where those compounds address mitochondrial function and protection, Urolithin A specifically addresses mitochondrial quality — clearing out the damaged mitochondria that impair the function of the healthy ones.
How it works
Mitophagy — Clearing Damaged Mitochondria
Mitophagy is selective autophagy targeting damaged mitochondria. The primary pathway: damaged mitochondria lose their membrane potential → PINK1 kinase accumulates on the outer mitochondrial membrane (normally imported and degraded) → PINK1 phosphorylates and recruits Parkin E3 ubiquitin ligase → Parkin ubiquitinates outer mitochondrial membrane proteins → ubiquitin-binding autophagy receptors (p62, NDP52, OPTN) recruit the autophagosome → the damaged mitochondrion is engulfed and degraded. Urolithin A activates this PINK1/Parkin pathway, specifically increasing the rate at which damaged mitochondria are identified and cleared.
Mitochondrial Biogenesis — The Follow-Up
Removing damaged mitochondria triggers compensatory mitochondrial biogenesis via PGC-1α — the master regulator of mitochondrial gene expression. The net effect of Urolithin A: fewer damaged mitochondria plus more newly synthesized healthy mitochondria equals higher average mitochondrial quality, better electron transport chain efficiency, reduced ROS, and improved cellular energy production. This improvement in mitochondrial pool quality is the basis for the muscle function improvements seen in human trials.
Why Gut Microbiome Dependence Matters
Ellagitannins — the dietary precursors in pomegranates and walnuts — must be converted to Urolithin A by specific gut bacteria, primarily Gordonibacter pamelaeae and Ellagibacter isourolithinifaciens. These bacteria are not present in all people and their abundance varies significantly. Studies show only 30–40% of people are "converters" who produce meaningful Urolithin A from dietary ellagitannins. Supplemental Urolithin A bypasses this variability — providing the bioactive compound directly regardless of microbiome status.
Lifespan Extension in Model Organisms
Urolithin A extends lifespan in C. elegans (worms) by 45% and in Drosophila (fruit flies). In aged mice, it improves muscle function and endurance comparable to exercise training effects in sedentary animals. The mitophagy mechanism is consistent across species — which is why it's taken seriously as a candidate longevity intervention in humans.
What the research shows
What the community reports
Urolithin A has the most mainstream-accessible community of any compound in the mitochondrial longevity space — Timeline's Mitopure branding has brought it to a broader wellness audience beyond the hardcore biohacker space. The evidence quality relative to other longevity supplements is genuinely superior.
THE MITOCHONDRIAL LONGEVITY STACK
Urolithin A: mitophagy — removes damaged mitochondria (quality control). MOTS-c: AMPK activation, metabolic efficiency, exercise mimetic (signaling). SS-31: inner mitochondrial membrane protection, ETC stabilization (structural). NAD+ (NMN/NR): sirtuin activation, fuel for mitochondrial enzymes (fuel supply). Each compound addresses a different layer of mitochondrial health — Urolithin A's mitophagy is the quality control layer, most complementary to the others when the pool of mitochondria being protected, fueled, and signaled are the high-quality ones that remain after Urolithin A has cleared the damaged ones.
Common misconceptions
"Eating pomegranates achieves the same result."
60–70% of people cannot produce meaningful Urolithin A from dietary ellagitannins due to lacking the required gut bacteria. Even in converters, the amounts produced are inconsistent. Supplemental Urolithin A provides a standardized dose independent of microbiome status.
"Urolithin A is just another antioxidant supplement."
Urolithin A's primary mechanism is mitophagy induction — selectively removing damaged mitochondria. This is a fundamentally different mechanism from antioxidant supplementation, which neutralizes ROS but doesn't clear the damaged mitochondria generating them. Urolithin A addresses the root cause (damaged mitochondria) rather than the symptom (ROS).
"The effects are immediate."
Mitophagy is a slow, structural cellular process. The Phase II RCT showed improvements at 4 months — not weeks. Users who expect immediate effects like those from NAD+ IV will be disappointed. Urolithin A is a long-timeline intervention requiring consistent daily supplementation for months to show measurable results.
Open PepperLedger to track your Urolithin A protocol →
Free to join. No credit card. Ask the Coach how Urolithin A fits your mitochondrial stack.
Free to join · No credit card · 23-day Pro trial included